Madrid, 21 of November 2008 

Dear Pr. Belkacemi, 

Following our previous contacts as well the indications from Pr. Marsglia; I have the honour to  provide  you  with  some  specific  information  on  our  institution, Instituto  Madrileno  de  Oncologia (Grupo IMO) in order to formally submit our application for working closely with  the Association of Radiotherapy and Oncology of the Mediterranean Area (AROME). We would  be proud to collaborate with such a promising association, taking into consideration that we  both share strategic purposes. 

Since 1991, IMO is dedicated to introducing innovative radiation therapy techniques in Spain,  notably  Stereotactic  Radiosurgery  (more  than  3,000  patients  treated),  High  Dose  Brachytherapy,  IMRT  and  Tomotherapy,  what  makes  of IMO  one  of  the  most  complete  radiotherapy  platforms  of  Europe.  On  our  network  of  8  centres,  160  multidisciplinary  professionals work in a safe and comfortable environment being responsive to the needs of  around 4,000 patients every year (25,000 patients have been treated so far). These clinical  activities are performed under strict quality & security protocols and criteria based on the  most demanding international standards.  

Grupo IMO is also keen on developing scientific & training programmes by means of Fundaci n  Grupo  IMO^*,  its  non  profit  branch  which  works  in  cooperation with  public  and  private  institutions with the aim of promoting knowledge, research and training for radio-oncologists  and radio-physicists. Accordingly, we suggest you to consider our current training programmes  (a fellowship of 1,500? per month and accommodation, is included) such as:    

·  The  International  Master  of  Advanced  Technologies  on  Radiation  Therapy  with  the  support of a Spanish University. The aim of this full-time programme is to broaden the  knowledge of practitioners on new RT technologies. For the first edition (2009), we  are  providing  access  for  12  junior  fellows  who  might  be  interested  on  one-year  fellowship. The programme will involve lectures and seminars each week in addition  to practical activities in our network of facilities. 

·  Diploma  Programmes  for  “Clinical  Observers”,  focusing  on  practical  activities  regarding IMRT and Brachytherapy techniques. These programmes take place in our  facilities in Alicante and Murcia (on the Mediterranean coast) and include a part-time  rotation at the TomoTherpy Centre in Madrid. 

We would also like to underline that there might be further opportunities for collaborate to  be  seized,  in  parallel  to  our  international  expansion.  More  precisely,  we  are  currently  supporting local doctors to set up both RT facilities in Tangier & Tirana and have reached a  scientific agreement with the Centre Medical de Forcilles (PSPH, Ile-de-France) in order to  update its RT service by means of the installation of 2 new Linear Accelerators in the period  of 2008-2010. Forcilles is already considered a reference centre for Elekta & IMPAC training  practices. 

In any case, I would personally like to thank you very much for your time and for the good  reception you have provided to our proposals.

           David Luengo

International Director Grupo IMO

Email: imo@grupoimo.com 

Fax: +34 91 413 4940 

Tel: +34 91 515 2000 

Plaza Republica Argentina, 7 Madrid 28002 

Grupo IMO – Instituto Madrileno de Oncologia 

back